Sand Blasting Machines Market Estimated to Surpass $441.1 Million By 2020

The global sand blasting machines market is expected to reach USD 441.1 million by 2020, according to a new study by Grand View Research, Inc. Breakthroughs in robotic sand blasting technology as a result of investments by key industry participants is expected to drive the market over the forecast period. Increased demand from end-use industries such as construction, automotive, and aerospace is expected to favorably impact market growth.

Shot blasting machines have replaced sand blasting machines in several applications to alleviate the risk of lung diseases caused due to inhalation of silica, which may pose a challenge to market growth. Governments of many countries such as the U.S., UK and Turkey have restricted the use of blast cleaning abrasives containing more than 0.1% free silica, which may hamper demand over the next six years.

Access Research Report of Sand Blasting Machines Market@
www.grandviewresearch.com/industry-analysis/sand-blasting-machines-market

Further key findings from the study suggest:

• Global sand blasting machines market shipments were estimated at 86,018 units in 2013, which is expected to reach 121,845 units by 2020, growing at a CAGR of 5.1% from 2014 to 2020.
• Industrial sand blasting machines accounted for over 80% of the market revenue in 2013. The mini sand blasting machines market is expected to gain prominence over the next six years as sandblasting has substituted numerous domestic tasks such as paint and rust removal.
• Sand blasting machines market demand is expected to be the highest in Asia Pacific owing to extensive use in construction, automotive, and infrastructure sectors coupled with significant contribution by the Chinese market to global volume and revenue generation. Demand for mini sand blasting machines is higher in North America, where they are used for automotive as well as home improvement applications.
• The market is extremely fragmented in nature; Clemco Industries Corp. emerged as the leading market player in 2013. The company sells blasting machines under four distinct brands, each catering to a specific application area, and also develops equipment targeted at operator safety. Other market players include Trinity Tool Company, Tools USA, C.M. Surface, and ACE.

Grand View Research has segmented the global sand blasting machines market on the basis of product and region:

Sand Blasting Machines Product Outlook (Volume, Unit Shipments & Revenue, USD Million; 2012 - 2020)

• Mini sand blasting machines
• Industrial sand blasting machines

Sand Blasting Machines Regional Outlook (Volume, Unit Shipments & Revenue, USD Million; 2012 - 2020)

• North America
• Europe
• Asia Pacific
• RoW

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Automotive Air Filters Market to Account for $5.4 Billion by 2025

The global automotive air filters market size is expected to reach USD 5.4 billion by 2025, expanding at a CAGR of 4.8%, according to a new report by Grand View Research, Inc. Stringent government regulations related to automotive emissions, coupled with rising fuel-efficient vehicles, are likely to propel market growth.

Increasing global environmental pollution, coupled with stringent environmental regulations implemented by governments and NGOs, is expected to drive the overall market over the forecast period. In addition, initiatives undertaken by associations such as Car Care Council and Environmental Protection Agency are likely to spread awareness about the product among automotive manufacturers across the globe, thereby driving the market growth.

Rising automotive production in developing economies such as India, China, and Indonesia is projected to boost the demand for this product in the automotive industry. In addition, increasing air pollution in the aforementioned countries has resulted in implementation of strict emission regulations, which is further estimated to drive the market.

Major cities across the globe had more particulate concentration than the required values in 2014. This forced governments to advocate the use of efficient emission systems. Therefore, the market is expected to benefit from these government initiatives as air filters are a major contributor toward increasing engine efficiency.

Key market players including Mann+Hummel Holding GMBH; K&N Engineering, Inc.; Cummins Inc.; Mahle GmbH; and Robert Bosch GmbH are engaged in the manufacturing and distribution of a variety of products. In addition, these players are involved in establishing a strong distribution network across the globe by implementing strategies such as mergers, acquisitions, and joint ventures.

Access Research Report of Automotive Air Filters Market @https://www.grandviewresearch.com/industry-analysis/automotive-air-filters-market

Further key findings from the report suggest:

• Cabin filters accounted for a market share of 49.5% in 2018, owing to their usage for maintaining a steady stream of fresh air in the vehicle cabin, coupled with their high frequency of replacement in automobiles
• The passenger car application segment dominated the automotive air filters market in 2018 and is estimated to reach USD 2.9 billion by 2025, due to rising demand for the product with growing automotive production across the globe
• The aftermarket end-use segment is projected to register notable gains and reach a revenue of USD 4.1 billion by 2025 driven by the replacement of cabin and intake filters on a regular basis as recommended by manufacturers
• The Asia Pacific region accounted for a market share of 50.9% in 2018 and is projected to reach USD 2.8 billion by 2025 owing to high automotive production in developing economies such as China, India, and Thailand
• Key participants are engaged in R&D activities to design and develop a wide-ranged product portfolio. In addition, the players are focusing on establishing and expanding their distribution networks across the globe.

Grand View Research has segmented the global automotive air filters market on the basis of product, application, end use, and region:

Automotive Air Filters Product Outlook (Revenue, USD Million, 2014 - 2025)

• Intake Filters
• Cabin Filters

Automotive Air Filters Application Outlook (Revenue, USD Million, 2014 - 2025)

• Passenger Cars
• Commercial Vehicles
• Two Wheelers

Automotive Air Filters End-use Outlook (Revenue, USD Million, 2014 - 2025)

• OEMs
• Aftermarket

Automotive Air Filters Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America 
  • US.
  • Canada
  • Mexico
• Europe 
  • Germany
  • UK.
  • France
  • Italy
  • Spain
• Asia Pacific 
  • China
  • India
  • Japan
• Central & South America
  • Brazil
  • Argentina
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Commercial Refrigeration Equipment Market is Expected to Amplify USD 48.61 Billion Value by 2025

The global commercial refrigeration equipment market size is projected to reach USD 48.61billion by 2025, growing at a CAGR of 5.4% over the forecast period, according to a new report by Grand View Research, Inc. Advancements in refrigeration technologies along with the changing food habits are expected to impel the market growth over the forecast period. The refrigerators & freezers is anticipated to emerge as the fastest-growing product segment with a CAGR of 6.4% from 2019 to 2025.

Innovation in magnetic refrigeration systems and other emerging technologies are also expected to have a positive impact on the market growth. Super markets are one of the most prominent retail channels for such equipment. The segment was valued at USD 2.20 billion in 2018 and is projected to maintain the dominance in future due to increasing number of supermarkets and hypermarkets in developing countries, such as China and India .Growing disposable income levels and improving standards of living in the emerging countries are also boosting the growth of super and hypermarkets.

The convenience store segment is said to register the highest CAGR of 6.1% over the forecast period. North America is a prominent region in the global market as it is the biggest manufacturer and exporter of the product. The region accounted for a market share of more than 32% in 2018. However, Asia Pacific is expected to emerge as the fastest-growing market from 2019 to 2025, owing to rise in the product manufacturing in this region.

Access Research Report of Commercial Refrigeration Equipment Market @ https://www.grandviewresearch.com/industry-analysis/commercial-refrigeration-equipment-market

Further key findings from the study suggest:

• The refrigerators &freezers segment is expected to reach USD 12.31 billion by 2025 at a CAGR of 6.4% from 2019 to 2025
• Technological advancements in refrigerators are anticipated to boost their demand in the food service and production segment
• F&B distribution is expected to be the fastest-growing application segment at a CAGR of 6.3% over the forecast years
• Key companies in the commercial refrigeration equipment market are Dover Corp.; Daikin Industries Ltd.; Carrier Commercial Refrigeration, Inc.; Johnson Control, Inc.; and Haier Group Corp.

Grand View Research has segmented the global commercial refrigeration equipment market on the basis of product, retail channel, application, and region:

Commercial Refrigeration Equipment Product Outlook (Revenue, USD Million, 2015 - 2025)

• Transportation Refrigeration Equipment
• Refrigerators & Freezers
• Beverage Refrigeration
• Display Showcases
  • Self-contained
  • Remotely Operated
• Ice Merchandisers & Ice Vending Equipment
• Others

Commercial Refrigeration Equipment Retail Channel Outlook (Revenue, USD Million, 2015 - 2025)

• Hypermarket
• Supermarket
• Convenience Store
• Specialty Store
• Others

Commercial Refrigeration Equipment Application Outlook (Revenue, USD Million, 2015 - 2025)

• Food Service
• Food & Beverage Retail
• Food & Beverage Distribution
• Food & Beverage Production
• Others

Commercial Refrigeration Equipment Regional Outlook (Revenue, USD Million, 2015 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • China
  • India
  • Japan
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Business Process Management Market to Record an Exponential CAGR by 2024

The global business process management (BPM) market is expected to reach USD 23.04 billion by 2024, according to a new study by Grand View Research, Inc. The growth is attributed to the increasing number of benefits offered by the BPM solution, including better productivity, ease of use, flexibility, and reduction in the time to wait for customers. The growing need for the integration of key functional areas in an organization is also expected to propel demand over the next eight years. The business process management software exhibits high avenues in various application areas, especially in the IT & telecom and healthcare sectors. This may be due to its capabilities of monitoring individual processes of the entire lifecycle.

Organizations restructuring their business processes are most likely to adopt the BPM software. Several regulations, including ObamaCare and (Single Euro Payments Area) SEPA, are analyzed to significantly catapult the demand over the forecast period. Obamacare focuses on providing affordable health insurance to the U.S. citizens with the introduction of new taxes and tax breaks. The European Union introduced SEPA to simplify the inter-country bank transfers. Security concerns related to the cloud-based BPM solutions are anticipated to hinder the market growth. Additionally, the lack of knowledge in order to successfully implement business process management solutions in an organization is a key challenge for this industry.

Want to Access Research Report of Business Process Management Market Click the Link Below:

http://www.grandviewresearch.com/industry-analysis/business-process-management-bpm-market

Further key findings from the study suggest:

• The process modeling and automation solution segment dominated the BPM market in terms of revenue in 2015. This is attributed to the growing need for process improvement in the manufacturing as well as service industry.
• The uses of the BPM solutions in the hospital management system, including bed management and patient monitoring, are anticipated to be the key factor fostering growth in the healthcare sector.
• The cloud-based BPM solutions are expected to observe a high adoption among SMEs due to their features such as scalability offered at a very low cost. Cloud-based BPaaS providers are expected to target the healthcare sector due to the growing IT spending by hospitals and pharmaceuticals.
• Large enterprises dominated the industry accounting for more than 60% of total market revenue share in 2015. The large share is primarily driven by the focus of the enterprise to build central functionality in order to enhance the operational efficiency.
• North America dominated the industry with more than 30% share in 2015. This is attributed to its early adoption, primarily in the government and BFSI sectors. Asia Pacific is anticipated to witness a considerable growth owing to the large scale industrialization and emergence of several startups in India, China, and the ASEAN region.
• The prominent industry participants include IBM Corp., Microsoft Corp., Oracle Corp., SAP SE, Appian Corp., and PegaSystems Inc. A strong focus on the research & development initiatives is helping solution providers to create its presence in the competitive environment. Merger & acquisition is also anticipated to be a key strategy used to diversify the developer’s competency to provide different solutions under a single roof.

Grand View Research has segmented the global Business Process Management (BPM) market on the basis of solution, application, deployment, end-user, and region:

BPM Solution Outlook (USD Million; 2014 - 2024)

• Automation
• Process Modeling
• Content & Document Management
• Monitoring & Optimization
• Integration
• Others

BPM Application Outlook (USD Million; 2014 - 2024)

• BFSI
• IT & Telecom
• Retail
• Manufacturing
• Healthcare
• Government & Defense
• Others

BPM Deployment Outlook (USD Million; 2014 - 2024)

• Cloud-based
• On-Premise

BPM End-user Outlook (USD Million; 2014 - 2024)

• SMEs
• Large Enterprise

BPM Regional Outlook (USD Million; 2014 - 2024)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East & Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Nuclear Medicine Market Size Worth $12.6 Billion By 2027

The global nuclear medicine market size is expected to reach USD 12.6 billion by 2027, expanding at a CAGR of 9.5%, according to a new report by Grand View Research, Inc. Research and development of advanced technologies by the key players for diagnosis and treatment of diseases is expected to drive the radiopharmaceuticals market.

For instance, in May 2019, GE Healthcare with Indi Molecular, Inc., collaborated to develop Protein Catalyzed Capture (PCC) technology and immune cell-targeted PET tracer candidates. This diagnostic tool will help in better understanding of patient’s immune cell and in early treatment response.

Rising prevalence of cancer and cardiovascular diseases is one of the major factors responsible for market growth. Moreover, high prevalence of cancer in emerging Asian countries is creating huge demand for radiopharmaceuticals in diagnosing the disease. For instance, according to the GLOBOCAN, in 2018, approximately 48.4% of cancer cases were registered in Asia.

In addition, presence of standard guidelines prepared by regulatory authorities for radiopharmaceuticals is expected to accelerate market growth. For instance, in August 2019, FDA published a guideline for non-clinical studies and product labelling that are not covered by FDA and ICH guidelines for radiopharmaceuticals used in the treatment of cancer.

Manufacturers are focusing on development of innovative technologies to produce medical isotopes that can fulfill the increasing demand for nuclear medicines. For instance, in October 2018, with the support of ASML, The Institute For Radioelements (IRE) developed and built an electron beamline to manufacture medical isotope molybdenum 99 (Mo-99). Due to this innovative technology, the process of production is waste-free and non-fission.

In addition, research centers and hospitals are launching novel nuclear medicine techniques to treat various diseases at an affordable cost as compared to the existing treatments. For instance, in August 2017, the Kovai Medical Centre and Hospital (KMCH) had launched Rhenium 188 Lipiodol to treat liver cancer and other diseases such as metastatic bone pain, rheumatoid arthritis, and hemophilic bleeding joints at low cost with lesser hospitalization.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/nuclear-medicines-market

Further key findings from the study suggest:

• In 2019, the SPECT segment had dominated the market owing to integration of SPECT with X-ray/CT that has gained more acceptance and proved to be useful in many clinical situations due to its high accuracy
• PET diagnostic nuclear medicine is expected to witness the fastest growth over the forecast period owing to the increasing adoption of high resolution PET scanners
• In case of the therapeutic segment, brachytherapy is anticipated to be the fastest growing segment due to the higher radiation protection as compared to other treatment options
• The oncology application segment dominated the nuclear medicine market in 2019 owing to the presence of pipeline drugs and high prevalence of cancer
• The market in Asia Pacific is projected to witness the fastest growth during the forecast period owing to the high unmet needs and development of radiopharmaceuticals for diagnosis and treatment of various diseases
• Key players in the market include companies such as Eckert and Ziegler Group Nordion, Inc.; Bracco Imaging S.p.A.; and GE Healthcare as well as government organizations such as Department of Atomic Energy and Australian Nuclear Science and Technology Organization (ANSTO).

Grand View Research has segmented the global nuclear medicine market on the basis of product, application, and region:

Nuclear Medicine/Radiopharmaceuticals Product Outlook (Revenue, USD Million, 2016 - 2027)

• Diagnostic products
  • SPECT
    • TC-99m
    • TL-201
    • GA-67
    • I-123
    • Other SPECT products
  • PET
    • F-18
    • SR-82/RB-82
    • Other PET products
  • Therapeutic Products
    • Alpha Emitters
      • RA-223
      • Other alpha emitters
    • Beta Emitters
      • I-131
      • Y-90
      • SM-153
      • Re-186
      • Lu-117
      • Other beta emitters
    • Brachytherapy
      • Cesium-131
      • Iodine-125
      • Palladium-103
      • Iridium-192
      • Other brachytherapy products

Nuclear Medicine/Radiopharmaceuticals Application Outlook (Revenue, USD Million, 2016 - 2027)

• Cardiology
• Neurology
• Oncology
• Thyroid
• Lymphoma
• Bone Metastasis
• Endocrine Tumor
• Others

Nuclear Medicine/Radiopharmaceuticals Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US
  • Canada
• Europe
  • Germany
  • UK.
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Singapore
  • Malaysia
  • New Zealand
  • South Korea
  • Philippines
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • South Africa
  • Israel
  • Turkey

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Antifungal Drugs Market Size Worth $12.7 Billion By 2025

The global antifungal drugs market size is expected to reach USD 12.7 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 1.5% during the forecast period. Increasing incidence of fungal infections worldwide is the key factor stoking the growth of the market. In addition, rise in adoption of immunosuppressive and antineoplastic agents, prosthetic devices and grafts, and broad-spectrum antibiotics has resulted in increased incidence of fungal infections in recent years.

According to statistics published by the Centers of Disease Control and Prevention in 2017, it has been estimated that every year, nearly 220,000 new individuals are affected by cryptococcal meningitis, which is a brain infection and has resulted in 181,000 deaths per year around the world. Most of the deaths were reported in sub-Saharan Africa, due to high prevalence of HIV/AIDS. This indicates the potential demand for antifungal drugs due to high prevalence of mycological infections around the globe.

As aged people are more prone to infectious diseases and chronic conditions, including HIV and cancer, rise in geriatric population worldwide is likely to stir up the demand for antifungals to treat opportunistic fungal infections. The demand for fungistatic agents is estimated to remain strong through 2025 due to mounting cases of fungal infections that are difficult to diagnose, yielding high mortality and morbidity rates.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/antifungal-drugs-market

Further key findings from the study suggest:

• Several types of fungicidal preparations, such as creams, sprays, tablets, & injections, are available. Increasing adoption of these products is anticipated to drive the market during the forecast period
• The echinocandins segment is anticipated to exhibit lucrative growth owing to their cell wall-specific fungicidal property coupled with their broad-spectrum activity against Aspergillusand Candida species without cross-resistance risks
• The candidiasis indication segment is expected to witness the fastest CAGR over the forecast period due to increasing drug resistance of the Candida species to Azoles
• North America held the largest market share in 2017. The growth of the market can be attributed to higher awareness levels pertaining to treatment of fungal infection and presence of a large target population
• Asia pacific is projected to register the fastest growth during the forecast period due to improving healthcare facilities coupled with rising government initiatives to create awareness of infectious diseases among the population
• Companies are focusing on development of effective therapeutic agents for treatment of systemic fungal infections in immune-compromised patients
• Numerous ongoing public-private partnership agreements in the pharmaceutical industry for development of novel therapeutics is poised to provide the market with lucrative growth opportunities. For instance, Astellas Pharma partnered with Vical Incorporated for the development of VL-2397, an antifungal drug for the treatment of pulmonary aspergillus.

Grand View Research has segmented the global antifungal drugs market by drug class, indication, and region:

Antifungal Drug Class Outlook (Revenue, USD Million, 2014 - 2025)

• Azoles
  • Voriconazole (Vfend)
  • Posaconazole (Noxafil)
  • Clotrimazole (Canesten)
  • Isavuconazole (CRESEMBA)
  • Others
• Echinocandins
  • Caspofungin (Cancidas)
  • Micafungin (Mycamine/ Funguard)
  • Others
• Polyenes
  • Amphotericin (AmBisome)
  • Others
• Allylamines
  • Terbinafine (Lamisil)
  • Others
• Others

Antifungal Drugs Indication Outlook (Revenue, USD Million, 2014 - 2025)

• Dermatophytosis
• Aspergillosis
• Candidiasis
  • Invasive Candidiasis
  • Vulvovaginal Candidiasis (VVC)
  • Mouth/Throat/Esophageal Candidiasis
  • Other Candida Infections
• Others

Antifungal Drugs Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Market for X-ray Photoelectron Spectroscopy to Reflect Steadfast Expansion by 2022

The global XPS market is expected to reach USD 712.4 million by 2022, according to a new report by Grand View Research, Inc. Growing application of XPS technology in different industries such as healthcare, semiconductors, aerospace, automotive, and electronics along with rising demand for research and development across all these industries is expected to drive the XPS market over the forecast period.

In addition, rising popularity of hyphenated technologies and other technological advancements such as hard X-ray photoelectron spectroscopy (HAXPES) has prompted the growth of the X-ray photoelectron spectroscopy market. The ability of XPS to accurately identify contamination in the provided sample is also expected to contribute towards boosting usage rates.

Rising demand for XPS technique for drug safety and medical research is expected to serve the market as a future growth opportunity. Presence of supportive government initiatives such as the “Safe Use Initiative” by FDA and “Drug Safety Information Survey” introduced by Health Canada for creating awareness regarding medical research and development are some notable examples likely to provide manufacturers with lucrative growth opportunities.

Access Research Report of X-ray Photoelectron Spectroscopy Market@
http://www.grandviewresearch.com/industry-analysis/xps-market

Further key findings from the report suggest:

• The global element detection market is anticipated to reach 257.05 million by 2022, at a CAGR of 6.29% from 2015 to 2022
• In terms of usage, contamination detection segment is expected to show the fastest growth during the forecast period
• In terms of application, healthcare segment is expected to dominate the market over the forecast period
• Asia pacific is expected to show the fastest growth in XPS market over the forecast period
• North America is expected to dominate the XPS market during the forecast period
• The market is partially consolidated and competitive in nature, with presence of global multinational players.
• Some of the key companies present in the market include Thermo Fisher Scientific, Kratos Analytical, Evan Analytical Group (EAG), Intertek, V G Scienta, Yokogawa, Kett and Mitsubishi Electric.                                                                                                        

Grand View Research has segmented the global XPS market on the basis of usage, application and region:

X-ray Photoelectron Spectroscopy Usage Type Outlook (Revenue, USD Million, 2012 - 2022)

• Element Detection
• Contamination Detection
• Density Estimation
• Empirical formula Determination

X-ray Photoelectron Spectroscopy Application Type Outlook (Revenue, USD Million, 2012 - 2022)

• Healthcare
• Semiconductors
• Electronics
• Aerospace
• Automotive
• Others

X-ray Photoelectron Spectroscopy Regional Outlook (Revenue, USD Million, 2012 - 2022)

• North America
  • US.
  • Canada
• Europe
  • UK
  • Germany
  • France
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Brazil
  • Mexico
• MEA
  • South Africa
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Needle-Free Drug Delivery Devices Market Share, Industry Size ,Growth Analysis And Forecast To 2025

The Report Needle-Free Drug Delivery Devices Market Size, Share & Trends Analysis Report By Application, By Technology (Jet Injectors, Inhaler, Transdermal Patch, Novel Needle Free), and Segment Forecasts, 2018 – 2025

The global needle-free drug delivery device market size is poised to reach USD 16.27 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 10.5% during the forecast period. Rising usage of injections in healthcare settings such as hospitals, clinics, and ambulatory surgical centers has led to spread of infectious diseases such as Hepatitis B, Hepatitis C, and AIDS, especially in developing countries. This acts as a key driver for the needle-less drug delivery devices industry. Furthermore, rising collaborations between market players is further likely to increase competitiveness of this market. For instance, PharmaJet and Mundipharma entered into a partnership in 2018 for distributing its needle free injectors over 120 markets globally.

Moreover, technological advancements in healthcare are expected to open new avenues for market players in applications such as cancer, AIDS, and Ataxic Cerebral Palsy. For instance, polycarbonate materials are being utilized in needle free injectors owing to their advantages such as design flexibility, toughness, light weight, and process ability. The most recent example of such technology is needle-free injection insulin delivery device manufactured by QS Medical Technology Co. (QS) in September 2018.

Access Research Report of Needle-Free Drug Delivery Devices Market @ www.grandviewresearch.com/industry-analysis/needle-free-drug-delivery-devices-market

Further key findings from the report suggest:

• Novel needle-less devices accounted for a significant share of more than 25.00% in 2017 owing to their wide array of applications
• Based on applications, the vaccine delivery segment is estimated to exhibit a lucrative growth rate over the forecast period due to its increasing usage for pediatric patients
• North America held the dominant share in the global arena in 2017, due to favorable government insurance policies and increased investments in R&D by healthcare companies
• For instance, In May 2018, U.S. Congress approved “right to try” bill where patients can try unproven medical treatments and devices in case of serious illness such as orphan diseases, including NETs
• The Asia Pacific needle-free medication transportation devices industry is anticipated to witness significant growth during the same period due to rising healthcare expenditure and growing investments by many companies in the healthcare sector
• Additionally, several countries in this region are implementing laws that cater to adoption of medical devices. For instance, the Korea-U.S. Free Trade Agreement (KORUS FTA) was implemented on March 15, 2012, in which most of the medical devices in Korea were made duty free
• Some of the key companies present in the market are Antares Pharma; Injex Pharma Ag; Verdict Media Limited; Valeritas, Inc.; and 3M Company
• Industry participants are involved in extensive research activities to develop novel needless drug delivery injectors for applications such as pain management, insulin drug delivery, and vaccines delivery.

Grand View Research has segmented the global needle-free medicine delivery device market on the basis of technology, application, and region:

Needle-Free Drug Delivery Device Technology Outlook (Revenue, USD Million, 2014 - 2025)

• Jet injectors
• Inhaler technology
• Transdermal patch technology
• Novel needle-free technologies

Needle-Free Drug Delivery Device Application Outlook (Revenue, USD Million, 2014 - 2025)

• Others Vaccine delivery
• Pain management
• Insulin delivery for diabetes
• Pediatric injections
• Others

Needle-Free Drug Delivery Device Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
• Asia Pacific
  • Japan
  • China
  • India
• Latin America
  • Mexico
  • Brazil
• Middle East & Africa
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Cell Line Development Market Share & Growth Rate by 2022

Global cell line development market size is expected to reach USD 6.24 billion by 2022, according to a new report by Grand View Research, Inc. The Increasing demand for monoclonal antibodies and patent expiration of blockbuster biologics are expected to drive the cell line development industry over the forecast period.

Increasing prevalence of autoimmune diseases and cancer are likely to increase the demand for accurate and cost effective treatment options which is expected to render a positive impact on market growth. In addition, improving healthcare infrastructure, economic development and favorable government initiatives promoting the growth of the biotechnology industry are factors contributing towards the growth of the cell line development market.

Ongoing R&D for stable & authentic cell lines and the introduction of technologically advanced processes such as single use bioreactor and micro bioreactor for large scale bioproduction are further expected to provide this market with lucrative future growth opportunities.

To request a sample copy or view summary of this report, click the link below:http://www.grandviewresearch.com/industry-analysis/cell-line-development-market

Further key findings from the study suggest:

• Reagent and media was the largest product market in 2014, owing to increasing number of cell culture procedures. Reagent and media are necessary components involved in cell line development procedures & cell culture and are cost intensive in nature. The market for reagent and media was valued at over 1.0 billion in 2014.
• Mammalian cell lines were widely used as a source for cell line development in 2014, owing to associated advantages such as accurate complex protein expression nature, critical for the production of monoclonal antibodies, vaccines, and biologics.
• Cell line development finds the largest application in the bioproduction of biologics, vaccines, Mabs, therapeutic proteins and biosimilars. Rising demand for monoclonal antibodies and vaccines are expected to boost the growth of this segment over the forecast period. The market for cell line development based bioproduction is also expected to witness lucrative growth of over 12.5% during the forecast period.
• North America was the largest market in 2014, with revenue estimated at over 800 million. The region’s market dominance is attributed to factors such as the growing adoption rates of cell culture techniques, presence of well developed healthcare infrastructure, supportive government initiatives and high healthcare expenditure levels.
• Asia Pacific cell line development market is anticipated to register rapid growth over the forecast period owing to factors such as the presence of high unmet needs, rising number of CROs (Contract Research Organization) providing pertinent services, growing R&D investments aimed at the development of stable cell lines and increasing biologics production.
• Key players in this market include European Collection of cell Cultures (ECACC), Lonza Group AG, GE Healthcare, Thermo Fisher Scientific Inc., Sartorious AG, Selexis SA, Wuxi AppTec Inc., Sigma-Aldrich Corporation, American Type Culture Collection (ATCC) and Corning Inc. 

Grand View Research has segmented the global cell line development market on the basis of product, source, type of cell line, application and region:

Global Cell Line Development Product Outlook (Revenue, USD Million, 2012 - 2022)

• Reagents and media
• Equipment Accessories and consumables
  • Incubators
  • Centrifuges
  • Bioreactors
  • Storage equipment
  • Microscopes

Global Cell Line Development Source Outlook (Revenue, USD Million, 2012 - 2022)

• Mammalian
• Non mammalian
  • Insects
  • Amphibians

Global Cell Line Development Type Of Cell Line Outlook (Revenue, USD Million, 2012 - 2022)

• Recombinant cell lines
• Hybridomas
• Continuous cell line
• Primary cell lines

Global Cell Line Development Application Outlook (Revenue, USD Million, 2012 - 2022)

• Bioproduction
• Drug discovery
• Toxicity testing
• Tissue engineering
• Research

Cell Line Development Regional Outlook (Revenue, USD Billion, 2014 - 2022)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Mexico
  • Brazil
• MEA
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Sports Nutrition Market Latest Innovations, Drivers and Industry Key Events by 2027

The global sports nutrition market size is expected to reach USD 31.0 billion by 2027, registering a CAGR of 8.9% over the forecast period, according to a new report by Grand View Research, Inc. Increasing importance of an active lifestyle owing to rise in sedentary jobs and shift in demographic base from core athletes to recreational athletes and lifestyle users are the key factors expected to drive the market. Moreover, increasing number of health and fitness centers and gyms, rising consumer awareness regarding the adoption of a healthy lifestyle, and demand for these products from athletes is expected to boost the market growth.

Widespread product availability due to the presence of large companies is expected to drive the demand for these products. For instance, in 2018, Amazon launched its private label sports supplement brand “OWN PWR” for U.S. consumers. Companies such as Glanbia Plc; Abbott Laboratories Inc.; Neutra Science Labs; Hormel Foods Corporation; and GNC Corporation are the key players operating in the market. Moreover, favorable government initiatives to promote health, growing base of health-conscious population, and rising awareness about sedentary health risks further drive the market.

Moreover, the U.S. population is becoming increasingly health-conscious and hence focuses on adopting an active lifestyle. The International Health, Racquet & Sportsclub Association (IHRSA), a Boston-based, commercial health clubs trade association, reported a 3.6% rise in the number of health club members, from 55.3 million in 2015 to 57.3 million in 2016. The number of health clubs in U.S. increased by 5.2%, from 36,540 in 2016 to 38,447 in 2017. These health clubs and fitness centers have consulting dietitians, which influences the consumption of sports nutrition products among trainers and fitness enthusiasts.

Access Research Report of Sports Nutrition Market @
https://www.grandviewresearch.com/industry-analysis/sports-nutrition-market

Further key findings from the report suggest:

• Sports supplements emerged as the largest product segment in 2019 with a share of over 80.0% of the global sports nutrition market owing to increasing commercialization of these supplements and wide product range including creatine and whey protein supplements
• On the basis of distribution channel, bricks and mortar dominated the market in 2019 owing to high consumer base for retail stores  
• Ecommerce is projected to be the fastest-growing segment over the forecast period owing to increasing popularity of ecommerce platforms and the associated benefits such as discounts and convenience
• North America dominated the global market in 2019 due to growing awareness about nutritional supplements and rise in government initiatives promoting sports-related activities
• Key players operating in the market include Glanbia plc; Hormel Foods Corporation; General Nutrition Centers, Inc.;Abbott; The Coca-Cola Company; and Clif Bar & Company.

Grand View Research has segmented the global sports nutrition market on the basis of product, distribution channel, and region:

Sports Nutrition Product Outlook (Revenue, USD Million, 2016 - 2027)

• Sports Drinks
• Sports Supplements
• Sports Foods

Sports Nutrition Distribution Channel Outlook (Revenue, USD Million, 2016 - 2027)

• Ecommerce
• Bricks and mortar

Sports Nutrition Regional Outlook (Revenue, USD Million, 2016 - 2027)

• NorthAmerica
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Microelectronic Medical Implants Market is Projected to Boost $57.12 Billion by 2025| Key Industry Participants Zoll Medical; Boston Scientific Corporation

The global microelectronic medical implants market size is anticipated to reach USD 57.12 billion by 2025, according to a new report by Grand View Research, Inc., registering a 9.8% CAGR during the forecast period. Increasing prevalence of cardiac disorders, epilepsy, and Parkinson’s disease, growing regulatory approvals for new devices and equipment, rising geriatric population, and introduction of new products are key factors driving market growth.

Regulatory authorities such as U.S. FDA have approved several new products and devices to be used by end users, most of which are equipped with new and innovative technologies that cater to varied consumer demands. These technologies also increase the ease of use of these products. For instance, in July 2017, Cochlear Ltd. introduced to the market a cochlear implant sound processor for iPhone. The U.S. FDA approved this innovation in June 2017.

Increasing prevalence of diseases such as epilepsy, cardiac disorders, and Parkinson’s disease have upped the sales of microelectronic electronic implants such as defibrillators, pacemakers, and neurostimulators. As per WHO, approximately 50 million people have epilepsy, globally, making it one of the most common neurological disorders. The condition can be treated using neurostimulators that prevent seizures.

Access Research Report of Microelectronic Medical Implants Market@
https://www.grandviewresearch.com/industry-analysis/microelectronic-medical-implants-market

Further key findings from the study suggest:

• By product, the pacemakers and defibrillators segment accounted for the largest share in 2016 owing to increasing prevalence of cardiovascular diseases and rising geriatric population
• RF technology accounted for the largest share in 2016 as it is employed in wireless implants and helps researchers and clinicians monitor patient health, capture physiological data, and study normal and abnormal functioning of the body
• North America commanded the largest share in the microelectronic medical implants market in 2016 and is expected to maintain its position over the forecast period. This is owing to favorable government policies, increasing FDA approvals for various medical devices in U.S., and high incidence of cardiac diseases
• Key market players include Zimmer Biomet Holdings, Inc.; Cochlear Ltd.; Medtronic plc; Abbott Laboratories; Zoll Medical; Boston Scientific Corporation; LivaNova PLC; Biotronik; Schiller; and Koninklijke Philips N.V.

Grand View Research has segmented the global microelectronic medical implants market on the basis of product, technology, and region: 

Microelectronic Medical Implants Product Outlook (Revenue, USD Million, 2014 - 2025)

• Pacemakers & Defibrillators
• Neurostimulators
• Implantable Drug Pumps
• Spinal Fusion Stimulators
• Cochlear Implants
• Ocular Implants
• Others

Microelectronic Medical Implants Technology Outlook (Revenue, USD Million, 2014 - 2025)

• RF Technology
• Sensors
• Other Technology

Microelectronic Medical Implants Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Genomics Market Will Increase at a CAGR of 7.7% During 2020 to 2027

The global genomics market size is expected to reach USD 31.1 billion by 2027, registering a CAGR of 7.7% over the forecast period, according to a new report by Grand View Research, Inc. Significant changes in disease management processes along with advancements in genomics and personalized medicine are expected to propel the market. 

Increasing pool of market innovators such as 23andMe,Oxford Nanopore Technologies, and Veritas Genetics that have launched breakthrough genomic technologies in recent years are also contributing toward market development. 23andMe has expertise in developing direct-to-consumer genomic tests targeted toward disease prognosis and has recently received FDA approval for its commercialization.

MinION - a trademark sequencing device of Oxford Nanopore Technologies, is witnessing significant traction owing to its ability to sequence any fragment length of DNA in real time. On the other hand, Veritas Genetics offers an affordable solution for a complete readout of the genomic sequence. Earlier procured only by doctors, these tests can now be taken by anyone curious about their DNA and costs approximately USD 1,000. The company has also begun the commercialization of this technique for newborn’s genomic sequencing applications in China in 2017.

Access Research Report of Genomics Market@
https://www.grandviewresearch.com/industry-analysis/genomics-market

Further key findings from the report suggest:

• The consumables and reagents deliverable segment is expected to register highest growth rate owing to high costs associated with specific essential reagents along with high volume requirement
• The computational services deliverable segment is set to expand at a considerable CAGR from 2020 - 2027 owing to the increasing demand for computational sequence alignment and analysis among molecular biologists
• Development of predictive biomarkers targeted toward diagnosis and monitoring and substantial investments by biotechnology and pharmaceutical companies have contributed significantly to the revenue generated by the biomarker discovery application segment in 2019
• Asia Pacific is a potentially lucrative market for genomics and is anticipated to expand at the highest CAGR of 9.1%
• Key players of genomics market include 23andMe; F. Hoffmann-La Roche Ltd.; BGI; Myriad Genetics Inc.; Danaher.; Pacific Biosciences; Illumina; Agilent Technologies; Thermo Fisher Scientific, Inc.; Foundation Medicine; Oxford Nanopore Technologies; and Bio-Rad Laboratories.

Grand View Research has segmented the global genomics market on the basis of deliverables, application and technology, end use, and region:

Genomics Deliverable Outlook (Revenue, USD Million, 2016 - 2027)

• Products
  • Instruments & Software
  • Consumables & Reagents
• Services
  • Core Genomics Services
  • NGS-based Services
  • Biomarker Translation Services
  • Computational Services
  • Others

Genomics Application & Technology Outlook (Revenue, USD Million, 2016 - 2027)

• Functional Genomics
  • Transfection
  • Real-time PCR
  • RNA interference
  • Mutational analysis
  • SNP analysis
  • Microarray analysis
• Epigenetics
  • Bisulfite sequencing
  • Chromatin immunoprecipitation-sequencing (ChIP & ChIP-Seq)
  • Methylated DNA immunoprecipitation (MeDIP)
  • High resolution melt (HRM)
  • Chromatin accessibility assays
  • Microarray analysis
• Pathway Analysis
  • Bead-based analysis
  • Microarray analysis
  • Real-time PCR
  • Proteomics tools (2-D PAGE; yeast 2-hybrid studies)
• Biomarker Discovery
  • Mass spectrometry
  • Real-time PCR
  • Microarray analysis
  • Statistical analysis
  • Bioinformatics
  • DNA sequencing
• Others

Genomics End-use Outlook (Revenue, USD Million, 2016 - 2027)

• Clinical & Research Laboratories
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

Genomics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • UK.
• Asia Pacific
  • Japan
  • China
• Latin America
  • Brazil
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Computational Biology Market Growth with Worldwide Industry Analysis by 2026

The global computational biology market size is expected to reach USD 13.6 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 21.3% during the forecast period. Rise in clinical studies in pharmacokinetics and pharmacogenomics for novel drug delivery and increase in the application of computational biology for bioinformatics R&D programs for the population based sequencing studies are fueling the market growth.

Rising use of computational tools in genomics, epi-genomics, proteomics, and meta-genomics to understand 3D protein structural analysis, protein-protein interactions, and gene sequencing and expression studies coupled with increasing research activities in drug designing and disease modeling is expected to drive the growth. However, lack of skilled resources to operate computational tools is expected to restrain the growth of the computational biology market during the forecast period.

Many pharmaceutical companies are seeking funding from angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based provider of product and services for drug discovery and development, received funding of USD 14.40 million from a group of investors. Brightstone Venture Capital was the major financer and was later joined by Crescent Ridge Partners, Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S. based Buffalo Niagara Medical Campus received funding of USD 5.0 million to speed up the discovery of new drugs. With this finding, the research institute is planning to procure and install drug discovery research instruments and other drug discovery platforms.

To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/computational-biology-market

Further key findings from the report suggest:

• Cellular and biological simulation is expected to expand at the fastest CAGR of over 15.0% over the forecast period. The shift in sequencing studies towards further analysis of the nature of various biological proteins as a part of the development of personalized medicine, is projected drive the growth
• Drug discovery and disease modelling applications led the market, accounting for 38.0% of the global market in terms of revenue in 2018. The factors responsible for this growth are extensive drug pipelines for the global drug manufacturing firms
• North America was the largest regional market, accounted for more than 45.0% of the global revenue in 2018. Increase in research activities for drug discovery processes and innovations in biological computation tools are anticipated to drive the growth
• Asia Pacific is anticipated to witness the fastest of around CAGR of 23.0% during the forecast period, due to increasing expenditure in the clinical studies for the pharmaco-kinetics and pharmaco-genomics
• Some of the players operating in the computational biology market include Chemical Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata AG; Certara; Insilico Biotechnology AG; Accelrys; Rhenovia Pharma SAS; Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.

Grand View Research has segmented the global computational biology market based on application, service, end use, and region:

Computational Biology Application Outlook (Revenue, USD Million 2015 - 2026)

• Cellular & Biological Simulation
  • Computational Genomics
    • Databases
    • Infrastructure/Hardware
    • Software & Services
  • Computational Proteomics
  • Pharmacogenomics
  • Others (Transcriptomics/Metabolomics)
• Drug Discovery & Disease Modelling
  • Target Identification
  • Target Validation
  • Lead Discovery
  • Lead Optimization
• Preclinical Drug Development
  • Pharmacokinetics
  • Pharmacodynamics
• Clinical Trials
  • Phase I
  • Phase II
  • Phase III
• Human Body Simulation Software

Computational Biology Services Outlook (Revenue, USD Million 2015 - 2026)

• In-house
• Contract

Computational Biology End-use Outlook (Revenue, USD Million 2015 - 2026)

• Academics
• Industry
• Commercial

Computational Biology Regional Outlook (Revenue, USD Million 2015 - 2026)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • France
  • Italy
  • Spain
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Guidewires Market Size to Expand at 6.3% CAGR from 2019 - 2025

The global guidewires market size is expected to reach USD 2.90 billion by 2025, at a CAGR 6.3% over a forecast period, according to a new report by Grand View Research, Inc. High prevalence of target diseases such as ischemic heart disease, brain aneurysm, and nephrolithiasis coupled with rise in preference for minimally invasive surgical procedures is anticipated to drive the growth. Increase in application of guidewires in neurovascular interventions is also among key factors driving the market.

Coronary heart disease is a major cause of disabilities and mortality globally. As per the Heart Disease and Stroke Statistics 2018, overall prevalence of myocardial infarction is nearly 7.9 million in U.S., which is 3% of the U.S. adult population, as of 2017. This study also states that the medical cost of coronary heart disease in projected to increase by 100% between 2013 and 2030. Moreover, as per OECD report, HEALTH AT A GLANCE 2015, the use of angioplasty has increased among the OECD countries, in the past 20 years. This is driving the demand for guidewires.

Technological advancements in terms of accessibility, improved flexibility with minimal deformity, and excellent tip shape retention is expected to drive the market. Motion Hybrid Wire Guide is an example of the technological advancement in guidewires. In January 2017, Cook Medical announced the launch of a two in one guidewire, Motion Hybrid Wire Guide. This product exhibits the features of Teflon fixed core guidewire and nitinol access guidewire into a single device.

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/guidewires-market

Further key findings from the report suggest:

• In 2018, coronary guidewires held the largest revenue share owing to high demand in cardiovascular interventions
• Neurovascular guidewires segment is expected to expand at a rapid CAGR of 10.2% over the forecast period owing to the technological advancements and rising incidences of neurovascular disorders
• In 2018, coated guidewires segment held the leading market share of 90.6% owing to high preference for coated guidewires in minimally invasive surgeries
• North America held the largest revenue share of 33.7% owing to high adoption of technologically advanced devices leading to improved treatment rates and rise in preference of minimally invasive surgeries
• Asia pacific is expected to witness the fastest CAGR of 8.4% over the forecast period owing to growing geriatric population and burden of chronic diseases coupled with improving treatment rates
• Key players operating in the guidewires market include Boston Scientific Corporation, Abbott, Cordis (Cardinal Health) Angiodynamics, Medtronic, Stryker, Cook, Codman Neuro, and Terumo Medical Corporation.

Grand View Research has segmented the global guidewires market on the basis of product, coatings, raw material, and region:

Guidewires Product Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• Coronary
• Peripheral
• Urology
• Neurovascular

Guidewires Coating Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• Coated
  • Hydrophilic
  • Hydrophobic
• Non coated

Guidewires Raw Materials Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• Nitinol
• Stainless Steel
• Others

Guidewires Regional Outlook (Volume, Thousand Units; Revenue, USD Million, 2014 - 2025)

• North America
  • US.
  • Canada
• Europe
  • UK.
  • Germany
  • Spain
  • France
  • Italy
  • Russia
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Tissue Diagnostics Market to Witness Soaring Growth During 2020 – 2027

The global tissue diagnostics market size is anticipated to reach USD 6.6 billion by 2027, growing at a CAGR of 5.9% during the forecast period, according to a new report by Grand View Research, Inc. Accelerating demand for automated tissue diagnostic systems due to the lack of skilled pathologists has driven the market. The advent of advanced imaging techniques, such as autofluorescence, that minimize the need for invasive diagnostics further supplement market growth.

The digitalization of tissue diagnostic techniques has resulted in the improvement of workflows and better patient care. Ongoing strategic models taken-up by key companies to enhance the efficiency of diagnostics also drives the market. For instance, in December 2019, Philips collaborated with Paige to provide clinical-grade artificial intelligence-based solutions to pathology laboratories. This enhanced the speed and accuracy of cancer diagnostics in laboratories.

Tissue diagnostic techniques, such as immunohistochemistry (IHC) or in situ hybridization, are used in companion diagnostics (CDx) to determine the quantity of a target analyte present in the sample. Introduction of CDx tests, such as the launch of the VENTANA HER2 Dual ISH CDx

To request a sample copy or view summary of this report, click the link below:https://www.grandviewresearch.com/industry-analysis/tissue-diagnostics-market

Further key findings from the report suggest:

• IHC tests are highly adopted as these tests are specific and helpful in identifying the variations between different types of cancer, resulting in the largest revenue share
• A rise in the investments for the development of advanced infrastructure to digitalize images is anticipated to drive the digital pathology segment with the fastest CAGR.
• Moreover, an increase in the demand for automated modalities owing to a dearth of skilled pathologists further compliments this growth
• A large number of breast cancer cases coupled with a rise in the application of digital image processing techniques on histopathological samples for breast cancer detection contributes to the largest share of breast cancer
• Prostate cancer is anticipated to register lucrative growth owing to the extensive ongoing research pertaining to early diagnosis and prevention of this disease
• Hospitals dominated the market in terms of revenue share due to the high adoption of tissue diagnostics solutions. These solutions provide accurate results in minimal time than conventional testing procedures
• North America accounted for the largest revenue share owing to increasing collaborations between pharmaceutical and biotech firms to expand their product offerings
• The requirement of better laboratory management systems, growing demand for novel patient care facilities, and favorable regulatory framework, boost the Asia Pacific market at a lucrative pace
• Abbott, QIAGEN, Roche, Siemens, Danaher, Thermo Fisher, and Merck are some key participants operating in the tissue diagnostics market
• Key vendors are engaged in novel product developments, partnership, and acquisition models to maintain their revenue share in the market.

Grand View Research has segmented the global tissue diagnostics market on the basis of technology and product, application, end use, and region:

Tissue Diagnostics Technology & Product Outlook (Revenue, USD Million, 2016 - 2027)

• Immunohistochemistry
  • Instruments
  • Slide Staining Systems
  • Tissue Microarrays
  • Tissue Processing Systems
  • Slide Scanners
  • Other products
  • Consumables
  • Antibodies
  • Reagents
  • Kits
• In Situ Hybridization
  • Instruments
  • Consumables
  • Software
• Primary & Special Staining
• Digital Pathology and Workflow
  • Whole Slide Imaging
  • Image Analysis Informatics
  • Information Management System Storage & Communication
• Anatomic Pathology
  • Instruments
  • Microtomes & Cryostat microtomes
  • Tissue processors
  • Automatic strainers
  • Other products
  • Consumables
  • Reagents & Antibodies
  • Probes & Kits
  • Others

Tissue Diagnostics Application Outlook (Revenue, USD Million, 2016 - 2027)

• Breast Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer
• Gastric Cancer
• Other Cancers

Tissue Diagnostics End-Use Outlook (Revenue, USD Million, 2016 - 2027)

• Hospitals
• Research Laboratories
• Pharmaceutical Organizations
• Contract Research Organizations (CROs)

Tissue Diagnostics Regional Outlook (Revenue, USD Million, 2016 - 2027)

• North America
  • US.
  • Canada
• Europe
  • Germany
  • France
  • Spain
• Asia Pacific
  • China
  • Japan
  • India
• Latin America
  • Brazil
  • Mexico
• Middle East and Africa (MEA)
  • South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.